CD274 and posterior cortical atrophy: With this in mind, a large study published in 2018 observed a significant increase in PD-L1 immunoreactivity in metastatic CRPC (mCRPC) compared to primary PCa 26, where expression is rare, and the Phase II KEYNOTE-199 study took this rationale into practice for mCRPC patients 27.